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Abstract
The purpose of this study was to identify the main health problems in Poland against global health problems using the latest Global Burden of Disease 
(GBD) study results. The burden of disease is assessed here in terms of: (i) time lost due to premature deaths and morbidity (expressed in Disability- 
-Adjusted Life Years – DALYs measure) and (ii) national income lost due to disease in Poland. The study presents the estimates of total DALYs, Years 
of Life Lost (YLL) caused by deaths, Years Lived with Disabilities (YLD), both in total (due to all causes) and attributable to chronic non-communica-
ble diseases (NCDs), in 2015 compared to year 1990. The economic value of time lost due to deaths and disability in Poland is measured using the 
method employed by the WHO Commission for Macroeconomics and Health, which makes the assumption that each DALY can be valued at between 
one and three annual GDPs per-capita for the country under study. In 2015 over 2.46 bln DALYs globally were lost due to all causes, of which 66.7% 
were due to NCDs and 18.2% were due to communicable diseases. Poland experienced over 11.3 mln DALYs in the year 2015, 81.9% of which were 
due to NCDs and 3.4% of which were due to communicable diseases. 68% of total DALYs globally and 41% in Poland were years of life lost due to 
deaths. 84% of the total years of life lost due to death in 2015 globally (69% in Poland) occurred under the age of 70 and are considered avoidable. 
Total income lost in Poland due to deaths in 2015 amounted to up to I$527 bln.
Key words: burden of disease study, disability-adjusted life-years (DALY), years of life lost (YLL), avoidable YLL, years lived with disability (YLD), chronic 
non-communicable diseases, national income lost
Słowa kluczowe: badanie obciążenia chorobami, lata życia skorygowane niesprawnością (DALY), utracone lata życia (YLL), YLL do uniknięcia, lata życia  
z niesprawnością (YLD), przewlekłe choroby niezakaźne, utracony dochód narodowy
Introduction
In conditions of limited resources, establishing in-
vestment priorities in the health care sector is essential. 
These investment priorities should reflect the most press-
ing health needs of a country and be focused on those 
diseases that constitute the greatest burden on society. 
The most important health problems are determined by 
assessing the burden posed by different diseases, injuries 
and risk factors on society. 
Burden of disease analyses are predominantly ap-
plied in creation of evidence-based health policy [1]. 
They provide data that enable the comparison of differ-
ent diseases, ordering them with respect to the costs they 
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impose on society as well as identifying areas where the 
health of the population can be potentially improved. In 
this way, they help develop preventative programmes 
geared towards solving the main problems which have 
been identified. Burden of disease studies provide a basis 
for allocating limited resources to those areas where the 
health and life of people is most at risk and where the 
greatest benefits for society can potentially be achieved. 
The results of disease burden analyses can also serve as 
a tool for benchmarking health care systems and help to 
understand the contribution of a health care system in 
preventing and treating particular diseases.
In the current study the existing methods of disease 
burden measurement were summarised and the main 
causes of health loss, both globally and in Poland, were 
identified using a complex measure of time lost and dis-
ability – DALY. 
The research questions were: What causes the most 
deaths and years of life lost both globally and in Poland? 
What portion of the lost years (due to death) is avoidable? 
What causes the most disability and combined death and 
disability in Poland? What is the national income lost due 
to disease in Poland? 
The secondary aim of this study was to illustrate the 
possible ways of using open access data sources available 
online, which can be easily applied to identify the main 
health problems in countries.
1. Methods and indicators for measuring a disease burden
A comprehensive analysis of disease burden requires 
making a correct epidemiological diagnosis (disease oc-
currence) and identifying the costs incurred in terms of 
both of treatment and social losses resulting from diseases 
as well as performing an analysis based on the method of 
calculating the direct and indirect costs of this treatment in 
addition to losses in economic growth. In order to identify 
the disease burden at national, regional or global levels, 
various approaches and units of measurement have been 
applied. The main indicators and approaches to measuring 
the disease burden can be divided into three groups which 
are presented in Figure 1. The first group – non-monetary 
units – includes: (i) natural units, consisting of mortality 
and morbidity indicators and (ii) time lost measures. 
The simplest and most commonly used measures for 
assessing the health level of a population are mortality 
rate indicators. However, they do not take into account 
losses caused by factors that do not result in death. This 
is because they do not assess burdens in the form of im-
paired physical or mental capacity during the course of 
the disease or the time preceding death. Actually, these 
measures assume that a person who does not die remains 
“healthy” [3]. In such a way, losses resulting from the 
complications of disease, as well as any pain or disability 
caused by a particular disease, are overlooked. These also 
fail to take into account other consequences of diseases 
– the costs which they entail for people suffering from 
the disease as well as for the public payer and for soci-
ety as a whole. Mortality rates do not usually show the 
social and economic dimension of death and disease in 
different periods of human life. In addition, it is believed 
that deaths at a younger age constitute a greater loss for 
society than deaths that occur over the age of 90.
Nevertheless, the indicator showing the number of 
deaths per 100,000 serves as a starting point for assessing 
the burden imposed on the health of a society by different 
diseases, risk factors and injuries in units of time lost.
1.1. Time lost measures without taking into account health-related 
quality of life – years of life lost caused by death
It was Dempsey [4] who first suggested that prema-
ture mortality should be measured in units of time lost 
[2, 5]. A number of variants of this method have been 
developed since 1947. These units measure the amount 
of time lost as a result of deaths caused by particular dis-
ease. The main idea is that death at an early age consti-
tutes a greater burden than death at a later age. Depend-
ing on how we count a lost period of life, the following 
measures have been developed: Potential Years of Life 
Lost (PYLL), measuring the number of years between 
the age of death and an arbitrary chosen limit of life; Pe-
riod Expected Years of Life Lost (PEYLL), counting the 
years lost equal to life expectancy at age of death (for 
males or females) in the country and Standard Expected 
Years of Life Lost (SEYLL), considering the period of 
life lost equal to the standard life expectancy at age of 
death (using a synthetic life table constructed from the 
lowest observed age-specific mortality rates for each 
age-group anywhere in the world). For more explanations 
and results on PEYLL and PYLL in Poland see [2] and 
Kozierkiewicz et al. in this issue [6].
1.2. Time lost measures taking into account health-related quality  
of life: DALY
In recent years, a number of studies have been tar-
geted towards creating a synthetic (universal) unit for 
measuring the health of society that integrates measures 
of burdens associated with both mortality and disability 
and that makes it possible to compare the burden of dif-
ferent diseases as well as the effects achieved by various 
medical interventions.
DALY (Disability-Adjusted Life Years) is a meas-
ure developed by experts of the World Bank and World 
Health Organization within the Global Burden of Disease 
(GBD) study, the first results of which were reported in 
1993 [7–9]. Since that time the burden of disease using 
DALY concept has been widely adopted by governments 
and international organizations in their attempts to iden-
tify the relative magnitude of different health problems. 
This information serves as crucial input in debates on the 
priorities of the health sector. 
DALY is a combination of two measures: loss of life 
as a result of premature death (YLL – Years of Life Lost) 
and loss of years in health due to disability caused by 
disease or injury (YLD – Years Lived with Disabilities). 
DALYs = YLLs + YLDs.
As a unit for measuring the disease burden in a soci-
ety as a whole, i.e. the sum of all burdens for particular 
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groups of people, DALY provides a basis for assessing 
not only the losses to society due to deaths, but also the 
losses resulting from disabilities caused by different dis-
eases. To any death from a particular cause is attributed 
YLLs number equal to the highest observed life expec-
tancy (standard life expectancy at age at death). The 
YLL calculation, accordingly, places more weight on the 
causes of deaths that occur in younger age groups. YLD 
are estimated based on incidence or prevalence number 
of disease cases and imply disability weights [3].
GBD methodology is constantly being improved and 
so far four phases have been distinguished in this pro-
cess1, 2. For this reason it is important to remain cautious 
when using GBD results published in previous years 
since they are not comparable.
2. Burden of disease measured in monetary units
Three approaches can be listed [2, 16]:
• The value of lost output: economic growth approach;
• The value of statistical life (VSL) approach;
• The cost-of-illness (CoI) approach.
2.1. Lost economic growth: assessing the cumulative value of lost 
output
This is a prognostic measure of the impact of disease 
on an economy’s gross domestic product (GDP) and 
economic growth that takes into account the impact of 
disease on reducing factors of production (labour and 
capital) in a country. This method was used by a team of 
experts led by Professor D. Bloom of the University of 
Harvard [16], assembled by the World Economic Forum 
to assess the economic burden of chronic non-commu-
nicable diseases globally in the years 2011–20303. The 
impact of these diseases on the economy (on the level 
of GDP) was estimated by assessing how these diseases 
reduce labour resources, physical capital and other fac-
tors in different countries. This approach used the WHO- 
-EPIC (WHO tool for Projecting the Economic Costs of 
Ill-Health) model prepared in 2006 [17], which provides 
a simulation of the macroeconomic consequences of 
chronic diseases (in 169 countries around the world) by 
looking at the effects of chronic diseases on economic 
growth. The EPIC model takes into account the negative 
impact of chronic diseases on the amount of labour and 
capital resources available4. The results are unequivocal: 
NCDs pose a substantial economic burden and this bur-
den will rise. The macroeconomic EPIC model simula-
tions suggest that five main chronic NCDs: cardiovascu-
lar disease, cancer, chronic respiratory diseases, diabetes, 
and mental illness, will cause a cumulative output loss of 
US$ 47 trillion globally over the next two decades [16]. 
2.2. The value of statistical life approach
The value of statistical life (VSL) approach reflects 
society’s willingness to pay (WTP) a certain sum with 
the aim of reducing the risk of disability or death caused 
by a particular disease. By placing a value on (establish-
ing a monetary value) loss of health, the VSL approach 
goes beyond simply measuring the impact of disease on 
GDP and economic growth. It reflects the preferences 
of a society. Various factors affecting the level of VSL 
are considered. The factors most commonly shaping VSL are 
age, the level of national income (or the average wage in 
a country, or the average wage in a specific branch associ-
ated with some degree of risk), the kind of risk involved 
(for example, death from cancer), and the moment when 
a risk may appear in the future. When the age factor is 
taken into account, the value of life of an individual suffer-
ing from a disease is adjusted in accordance with a fixed 
indicator, or a reduced value of life is considered together 
with age. Such a correction is called the “senior discount” 
[18]. Bloom et al. found that the value of life lost due to 
NCDs in 2010 is US$ 22.8 trillion and will double by 2030 
to US$ 43.4 trillion [16]. For more details on valuing sta-
tistical life and the disease burden results achieved, includ-
ing those for Poland using this approach, see [2, 16]. 
2.3. The cost-of-illness approach
This is the third method for measuring the disease 
burden on society in monetary units: the value of resourc-
es used or lost as a result of the disease is measured. This 
approach makes it possible to determine the potential 
savings that can be achieved as a result of preventative 
interventions.
Today’s costs of illness have their roots in studies pub-
lished in the 1950s and 1960s [19–22] when, as in present 
times, there was a debate over the most suitable approach 
to measuring improvement of population health. The best 
approach appeared to be using the results of earlier con-
ducted studies. In 1966 Dorothy Rice published a mono-
graph [22] in which she proposed a methodology for 
estimating the costs of a disease using information from 
existing data bases. This work became the de facto stand-
ard for future cost analyses of different diseases. In the 
following years, this approach was developed and applied 
on a wide scale by different agencies and governments to 
identify the costs of different diseases [23–29].
The cost-of-illness approach measures different kinds 
of costs, depending on the criteria used, to divide re-
sources into those used or lost caused by disease. Direct 
costs are the costs of medical care and non-medical costs 
incurred because of disease, such as the costs of transport 
to the health provider or caregiving costs – either paid 
or informal uncompensated care provided in the patient’s 
home. In turn, indirect costs (or also called productivity 
lost) are the value of production lost as a result of death 
or an individual’s inability to work during the time he or 
she is suffering from a disease. 
The third category of costs, encompassing the “psy-
chological” costs of disease and the costs caused by pain, 
i.e. the impact of a disease on an individual’s quality of 
life, are called intangible costs. This category is usually 
mentioned when determining the different elements of the 
disease costs. However, owing to the difficulties involved 
in measuring such costs (primarily because their content 
differs greatly from the other two cost categories), it is usu-
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ally not considered when estimating the costs of diseases 
[30, 31]. For a more in-depth explanation of the cost-of-
illness approach and the techniques used to value resources 
used and lost please consult [2, 26, 28, 29, 32, 33]. To our 
best knowledge there is no example of a cost-of-illness 
study summarising the costs of all diseases globally. The 
abovementioned study by Bloom et al. [16] attempted to 
measure the disease burden of chronic NCDs in the world. 
Due to the incomparability of the methods applied for each 
of the five main analysed NCDs the results were presented 
separately. The direct and indirect costs of illness for five 
distinct disease categories were [16]: 
• Cardiovascular diseases: US$ 863 billion in 2010, 
rising to US$ 1.04 trillion in 2030;
• Cancer: US$ 290 billion in 2010, rising to US$ 458 
billion in 2030;
• Diabetes: nearly US$ 500 billion in 2010, rising to at 
least US$ 745 billion in 2030;
• COPD: US$ 2.1 trillion in 2010 rising to US$ 4.8 tril-
lion in 2030;
• Mental illness: US$ 2.5 trillion in 2010 rising to US$ 
6.0 trillion by 2030.
3. Considering individual and intergenerational spillovers of 
disease
Disease burden analyses may also focus on illnesses 
consequences other than those summarised in the first 
two groups described above (monetary and non-monetary 
units). These are called individual and intergenerational 
disease spillovers and may include: the impaired ability 
of ill persons to play social roles successfully, poor nutri-
tion and lack of proper education for children, lost career 
opportunities both for persons with the disease and for 
their family members (Figure 1). 
A disease causes direct loss of well-being to an indi-
vidual. In their report, focusing on health investments in 
developing countries, the WHO Commission on Macro-
economics and Health [34] emphasised that there is a re-
duction in the “utility” of the individual as a result of poor 
health (even if there is no change in the level of goods and 
services consumed or in the life span of the individual) due 
to the likely significance of the long-term consequences of 
early disease episodes. Early disease may obstruct physical 
and cognitive development, which, in turn, may reduce an 
adult’s economic productivity. Reduced cognitive capac-
ity may lead to leaving school early, a lack of educational 
achievement, and reduced earnings in adulthood. 
The intergenerational spillover of disease also occurs 
[34]. When one individual in a family is affected by dis-
ease, it may have important adverse effects on other fam-
ily members, especially children. An adult’s illness may 
result in the poor health, or even death, of a previously 
healthy child because of a drop off in care giving and 
family income. A parent’s illness or death may, for ex-
ample, force a child to leave school prematurely in order 
to help support the family. The adult’s illness will also 
reduce the transfer of knowledge from parent to child.
Figure 1. Indicators and approaches to measuring disease burden 
Not taking
into account
health-related
quality of life
of persons
with the disease.
Taking
into account
health-related
quality of life
of persons
with the disease.
Measures:
PYLL,
PEYLL,
SEYLL.
Measures:
QALY,
DALY,
HALE.
Mortality
and morbidity:
● Number
of deaths
due to
the disease;
● Number
of persons
with
the disease;
● Cause specific
mortality rate;
● Prevalence
rates;
● Incidence
rates.
● Reduced
economic growth
(Value
of Lost Output
approach);
● Value
of Statistical
Life approach;
● Cost-of-Illness
approach.
● Impact
on households:
– Impaired ability
to play social
roles;
– Poor nutrition
and lack of proper
education
for children;
– Lost chances
of pursuing
a career of persons
with the disease
and their family
members.
Non-monetary Monetary Other
Time lost measures
Indicators of disease burden
Source: Author’s own elaboration based on Kissimova-Skarbek K., Koszty obciążenia chorobami, in: Golinowska S. (ed.), Od 
ekonomii do ekonomiki zdrowia. Podręcznik ekonomiki zdrowia, PWN, Warszawa 2015: 354–391 [2].
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Identification and recognition of individual and in-
tergenerational spillover of disease should be, but rarely 
are, considered in cost-of-illness studies (particularly in 
estimating indirect costs of the disease). It is believed that 
CoI literature often understates, for example, the costs of 
nonfatal chronic conditions at all stages of the life cycle 
[34] by not considering the above mentioned spillovers. 
These may be substantial and should be taken in-to con-
sideration when assessing indirect costs within the CoI 
studies.
4. The occurrence of diseases
Civilizational progress and medical advances have 
affected the balance (in terms of frequency) between the 
three main groups of diseases: (i) communicable, ma-
ternal, neonatal and nutritional, (ii) non-communicable 
diseases (NCDs) and (iii) injuries. At the present time, 
chronic non-communicable diseases, resulting both in 
death and permanent disability, impose the biggest bur-
den on society.
Characteristics of chronic diseases
According to WHO experts [35], the main chronic 
diseases are: heart disease and cerebral strokes (car-
diovascular diseases), neoplasms, asthma, obstructive 
pulmonary disease (chronic diseases of the respiratory 
system) as well as diabetes mellitus5. Neuropsychiatric 
diseases are also nowadays regarded as one of the most 
common non-communicable diseases.
Cardiovascular disease includes diseases affecting 
the heart and blood vessels as well as the conditions re-
sulting from poor blood flow caused by vascular disease. 
More than 82% of global deaths as a result of cardiovas-
cular disease are due to ischaemic heart disease, cerebral 
strokes (both haemorrhagic and ischaemic), hypertension 
and congestive heart failure. Over the course of the last 
decade cardiovascular disease has become the most im-
portant cause of death around the world (it accounts for 
almost 30% of all deaths as well as over 45% of deaths 
from chronic non-communicable diseases. In 2010, car-
diovascular diseases caused 15.6 million deaths around 
the world. 
Cancer consists in the rapid and excessive growth 
and division of abnormal cells in the body. These cells 
outlive normal cells and have the ability to make metasta-
ses and spread to other parts of the body as well as other 
organs. There are more than 100 different types of cancer 
as well as different risk factors contributing to the growth 
of cancers in different parts of the body. Cancers are the 
second biggest cause of death in the world, accounting 
for 16% of all deaths globally and 22% of global deaths 
due to NCDs. In 2015, 8.76 million people died of cancer 
globally. This translates into an increase of 54% com-
pared to 1990. 
Diabetes mellitus: Diabetes type 2 accounts for 
90–95% of all cases of diabetes mellitus. In 2015, over 
435 million people globally had diabetes [13], which rep-
resents a 30.6% increase compared to 2005. This number 
is expected to rise to over 642 million by 2040 if no ma-
jor preventative measures are taken [36]. A considerable 
number (around 50%) of cases of diabetes type 2 remain 
undiagnosed. Delayed diagnosis of diabetes mellitus as 
well as ineffective treatment of this condition may cause 
late complications of the disease, in particular vascular 
complications, which result in premature invalidity and 
increased mortality in this group of people. They include 
microvascular complications, such as nephropathy and 
retinopathy as well as macrovascular complications, e.g., 
heart attacks, heart failure, strokes and peripheral artery 
disease, e.g., diabetic foot. International Diabetes Federa-
tion estimates that about 5 million deaths in 2015 were 
due to diabetes [36], and it accounts for 9% of all deaths 
and 13% of deaths caused by NCDs globally. 
Chronic respiratory diseases together account for 
3.8 million deaths worldwide, 7% of all deaths globally 
and 10% of deaths due to chronic non-communicable 
diseases [37]. They are the fourth main cause of deaths 
globally. The most common diseases in this group are 
asthma, chronic obstructive pulmonary disease (COPD), 
respiratory allergies, occupational lung diseases, and pul-
monary hypertension. COPD refers to a group of progres-
sive pulmonary diseases which cause breathing difficul-
ties, including chronic bronchitis and emphysema.
COPD contributes to 3.8 million deaths each year 
[37] and accounts for 3–8% of all deaths in countries 
with a high national income and 4–9% of all deaths in 
countries with low and average national incomes [16]. 
Morbidity and mortality rates from COPD are expected 
to increase in the future. A causal relation exists be-
tween this disease and four main sources of exposure: 
tobacco smoking, smoke inside premises, environmen-
tal pollution and professional exposure to the effects 
of certain microparticles (e.g., asbestos). Despite the 
fact that the development of COPD can be checked be 
preventing exposure to the main risk factors, it cannot 
be cured fully according to the present state of medical 
knowledge.
Mental illness is a term referring to a group of 
medical conditions which affect the thinking, feeling 
and moods of an individual, his or her ability to relate 
to others and his or her ability to function in daily life. 
They are sometimes also referred to as mental disor-
ders, mental health or neuro-psychiatric diseases. These 
disorders affect the lives of hundreds of people around 
the world. In 2015 over 311 million people in the world 
were suffering from major depressive disorders and al-
most 64 million were dependent on alcohol [13]. Close 
to 900,000 people suffering from mental illness commit 
suicide every year [16].
Methods
The techniques for measuring the disease burden and 
health of a population illustrated with examples have 
been described in detail elsewhere [2, 5]. 
The present study focuses on two approaches to as-
sessing disease burden: (i) a GBD study that includes 
a DALY measure and (ii) the WHO Commission on 
Macroeconomics and Health, which values each unit of 
DALY at one or three times GDP per capita in the coun-
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try in the year being evaluated. As mentioned earlier, the 
DALY is calculated by adding Years of Life Lost (YLL) 
due to deaths to Years Lived with Disability (YLD). 
In accordance with the methodology adopted in the 
latest Global Burden of Disease (GBD) study [12], the 
global and Polish DALYs presented here are not age 
weighted, not discounted, and contain a higher (com-
pared to GBD-2010 study version) equal standard life 
expectancy at age of death. The normative life table of 
91.9 years at birth [12] has been used to calculate YLLs 
in order to avoid disparities both between countries and 
between males and females. Estimating YLDs involves 
three main steps [38]: (i) establishing the prevalence and 
incidence of causes and sequelae (health states caused by 
a disease, for exam ple, the blindness that can be caused 
by diabetes) related to disability, (ii) classifying these dis-
abilities according to their degree of severity, and (iii) 
combining these two results into one comprehensive 
measure of nonfatal health loss. Several data sources 
and techniques have been used in the present GBD 2015 
study, such as collecting data from government reports, 
data from population-based disease registries, antenatal 
clinic data, hospital discharge data, and other sources as 
well as modelling6 to generate estimates of the prevalence 
and incidence of disability-causing sequelae. To classify 
disability complications of diseases according to their 
degree of severity, surveys were conducted to establish 
disability weights, among other things. These weights are 
coefficients of severity on a scale of 0 to 1 attributed to 
each disability. These are used to estimate the period of 
life reduced due to disability [13]. 
The top ten health problems globally and in Poland 
in 2010 have been listed elsewhere [2, 39]. Presented in 
this paper, on the other hand, is the burden of diseases 
for 2015 compared with 1990 based on the results of the 
recently published GBD study [12, 13, 37]. This paper 
identifies the main causes of disease burden in different 
ways: 
• the top ten causes in the world and in Poland based on 
deaths per 100,000 in 2015 and the percentage change 
compared to 1990; 
• the ten main causes of DALYs, YLD and YLL in Po-
land in 2015 and the percentage change between 1990 
and 2015;
• the number of YLLs due to all causes in Poland over 
a 25 year period (1990–2015), and the percentage of 
avoidable YLLs (occurring below the age of 70);
• DALYs by age group and sex due to NCDs in Poland;
• the value of income lost due to all causes of death 
and unnecessary income lost (and in consequence – 
a downturn in economic development) due to prema-
ture deaths;
• the value of income lost due to DALYs caused by 
NCDs in Poland. 
The study also presents the distribution of DALYs in 
the working age population both globally and in Poland 
among three main groups of diseases – communicable 
diseases, maternal, neonatal and nutritional diseases, non-
communicable diseases, and injuries (external causes of 
mortality and morbidity), which indirectly demonstrates 
the impact of diseases on the economy. By way of com-
parison, we adopted the 15–59 age group (the most com-
monly used in publications) as the working age for both 
Poland and the world7. Our analyses for Poland by gender 
also concerned different working age periods, according 
to the working age ranges for males and females advised 
by the Central Statistical Office of Poland.
To estimate the amount of income lost in Poland, we 
used the method utilised by the WHO Commission on 
Macroeconomics and Health so as to give a direct esti-
mate of DALYs due to disease. It recommends valuing 
DALYs at between one and three times GDP per capita 
(referred to as CMH1 and CMH3, respectively) [34]. 
Constructing the CMH1 and CMH3 estimates required 
multiplying the annual number of DALYs by the rel-
evant multiple (1 or 3) of income per capita in Poland 
for the year in question. GDP per capita was presented 
in current International Dollars (I$). Future time lost due 
to deaths (YLL) and in consequence – income lost due 
to all causes in Poland in 2015 was discounted at a 3% 
discount rate. 
To determine the real change in income lost over 
time and to ensure international comparisons, levels of 
income lost in previous years have been converted to 
2015 prices using GDP deflators for Poland in respec-
tive years [40]. Next, values in 2015 national currency 
units (NCU) were converted to 2015 I$ by applying pur-
chasing power parity (PPP) conversion factors for GDP 
(NCU per I$) [41]. 
Results
1. Ranking of diseases by their burden, measured with death 
rate 
The average ranks of diseases and injuries globally, 
measured by the deaths per 100,000 rate in 2015 and the 
percentage change compared to the year 1990 are shown 
in Table I. We can observe the direction of the change 
in the top ten causes. In 2015 five of the ten main global 
causes of deaths were chronic non-communicable dis-
eases. Three of the NCD group causes have increased 
their position in the ranking. Neoplasms moved from the 
third rank in 1990 to the second rank in 2015. The global 
burden of diabetes mellitus also increased – shifted from 
the eighth place in 1990 to the fifth place in 2015. The 
burden of neurological disorders increased from rank 
eleven to rank seven (with an almost 47% increase within 
a 25 year period). 
Chronic NCDs were responsible for 90% of all deaths 
in Poland in 2015. 46% were due to cardiovascular dis-
eases, which still represent the main cause of death in 
Poland. The top ten causes of death in Poland in 2015 
ranked by number of deaths per 100,000 are presented 
in Table II. Even though the death rate due to ischemic 
heart disease in 2015 has decreased compared to 1990 by 
24.9%, it is still a main cause of death in Poland, causing 
270.56 deaths per 100,000. Alzheimer disease and other 
dementias had the highest percentage increase in the last 
25 years in Poland (73.4%).
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As in the global ranking, the top cause of mortality 
in Poland in 2015 was the cardiovascular disease group. 
Here (where a more detailed classification of diseases is 
used) ischemic heart disease together with cerebrovas-
cular disease are the first two out of the top ten causes of 
mortality. This cause has not moved from the first rank 
since 1990 in either Poland or in the world. However, 
compared to the global burden, the ratio in Poland of 
270.56 deaths due to ischemic heart disease per 100,000 
members of the population in 2015 (vs. 120.97 deaths 
per 100,000 globally [37]) is over two times higher 
than average global rate. The global death rate due to 
cardiovascular diseases in 2015 was 243.13 deaths per 
100,000 vs. 460.84 per 100,000 deaths in Poland in the 
same year [37].
On the other hand, unlike the global ranking where 
lower respiratory infections (from the communicable 
diseases group) have decreased their rank from third 
to fourth place, in Poland lower respiratory infections 
have increased their rank from 9th place in 1990 up to 
7th place in 2015. However, the rate of number of deaths 
per 100,000 population in Poland in 2015 was lower 
compared to the global burden of LRI (30.48 vs. 37.13 
[37]). 
2. Burden of disease measured with DALY
2.1. The global and national burden of disease in the years 1990–2015
In 2015 over 2.46 bln DALYs globally were lost due 
to all causes, of which 67.9% were years of life lost due 
to deaths [37]. 84% of the total years of life lost due to 
deaths (and 57.2% of all DALYs in year 2015) appeared 
under the age of 70 and are considered avoidable. 
The largest share of the global burden (60%) is at-
tributable to NCDs. In 2015 over 1.47 bln DALYs glob-
ally were due to NCDs. (Chart 1(a)). During the entire 
period of 1990–2015, the share of YLL was much higher 
than YLDs. Deaths caused a higher number of YLLs in 
males compared to females (Chart 1(b)). In females 
a minor decline in YLLs was observed in 2010 compared 
to 2005. The highest increase in DALYs due to NCDs in 
the 1990–2015 period was observed in disability (YLDs) 
caused by disease. Both sex groups have presented an 
increase in YLDs. 
Poland experienced over 11.3 mln DALYs in 2015, 
86.7% of which were due to NCDs, followed by inju-
ries (external causes of deaths and morbidity), respon-
sible for 9.3% of DALYs, and communicable diseases, 
Table I. Top 10 global problems in 2015, ranked by number of deaths per 100,000 population and percent change, 1990–2015, 
both sexes, all age groups
1990 ranking 2015 ranking Change
1 Cardiovascular diseases 1 Cardiovascular diseases (243.13) 2.41%
2 Diarrhoea/LRI/other 2 Neoplasms (118.91) 11.91%
3 Neoplasms 3 Diarrhoea/LRI/other (67.29) –55.37%
4 Chronic respiratory diseases 4 Chronic respiratory diseases (51.49) –22.4%
5 Neonatal disorders 5 Diabetes, urogenital, blood, and endocrine diseases  (46.25) 44.14%
6 Unintentional injuries 6 HIV/AIDS and tuberculosis(31.27) –7.47%
7 HIV/AIDS and tuberculosis 7 Neurological disorders (30.65) 46.84%
8 Diabetes, urogenital, blood,  and endocrine diseases 8
Neonatal disorders
(29.35) –55.73%
9 Transport injuries 9 Unintentional injuries(24.95) –35.14%
10 Neglected tropical disease and malaria 10 Transport injuries(19.9) –12.71%
11 Neurological disorders
14 Neglected tropical disease and malaria(11.44) –45.28%
I.    I. Communicable, maternal, neonatal, and nutritional diseases
II.  II. Non-communicable diseases
IIIIIII. Injuries
The ratio of number of deaths per 100,000 by cause in 2015 is provided in parentheses. LRI = lower respiratory infections.
Source: Author’s own elaboration based on data from Global Burden of Disease Study 2015. (GBD 2015) Results. Seattle United 
States: Institute for Health Metrics and Evaluation (IHME); accessed: 08.10.2016 [37].
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maternal and nutritional disorders, accounting for 4.0% 
of all-cause DALYs [37]. The NCDs showed a 4.7% 
decrease in the number of DALYs compared to 1990. 
Injuries – with a decline of 30.2% and the group of com-
municable, maternal, neonatal, and nutritional diseases 
showed the highest decline of DALYs – 56.25%, com-
pared to the 1990 number of DALYs. Chart 1(c) shows 
the number of YLL and YLD in Poland in the period of 
1990–2015 and Chart 1(d) – divides these values among 
both sex groups. Similar to the global trend for both sex 
groups considered together, in Poland an increase in 
YLDs due to NCDs has been observed during the last 25 
years (Chart 1(a) and (c)). In YLL due to deaths, Poland 
showed better achievement in averting YLLs compared 
to the entire world. This is further confirmed when ana-
lysing the number of YLLs by sex (Chart 1(b) and (d)). 
When observing DALYs over 25 years, the number of 
DALYs in Poland has slightly decreased (or stayed sta-
ble) as opposed to the global tendency where the number 
of DALYs has increased (Chart 1(a), (b), (c), (d)). 
2.2. The global and national burden of NCDs by age group
When the YLLs and YLDs due to NCDs in 2015 are 
presented by age groups the first observation is that in 
Poland the years of life lost due to both death and dis-
ability, appeared mainly over the age of 50 with few in 
the below 20 age group. In the entire world – the burden 
of NCDs (especially due to deaths) is substantial in the 
below age 20 age groups (Chart 2).
2.3. Ranking of diseases based on DALY in Poland in 2015 
The leading causes of disability in Poland are pre-
sented in Table III. At the top of the list are lower back 
and neck pain, sense organ diseases, depressive disorders 
and diabetes.
Table II. The top ten health problems in Poland, 2015, ranked by number of deaths per 100,000 population, both sexes, all age 
groups, and percent change, 1990–2015
1990 ranking 2015 ranking Change
1 Ischemic heart diseases 1 Ischemic heart diseases (270.56) –24.86%
2 Cerebrovascular disease 2 Cerebrovascular disease (113.78) –5.38%
3 Tracheal, bronchial, and lung cancer 3 Tracheal, bronchial, and lung cancer (61.56) 34.17%
4 Chronic obstructive pulmonary disease (COPD) 4
Alzheimer’s disease and other dementias
(46.27) 73.4%
5 Alzheimer’s disease and other dementias 5 Colon and rectal cancer(36.12) 45.14%
6 Colon and rectal cancer 6 Cardiomyopathy and myocarditis (31.96) 36.99%
7 Cardiomyopathy and myocarditis 7 Lower respiratory infections(30.48) 39.52%
8 Road injuries 8 COPD(28.99) 0.96%
9 Lower respiratory infections 9 Self-harm(21.36) 41.77%
10 Stomach cancer 10 Diabetes mellitus(17.19) 11.36%
12 Diabetes mellitus 12 Stomach cancer(14.65) –27.06%
13 Self-harm
18 Road injuries(12.06) –48.11%
I.   I. Communicable, maternal, neonatal, and nutritional diseases
I  III. Non-communicable diseases
IIIIII. Injuries
The ratio of number of deaths per 100,000 by cause in year 2015 is provided in parentheses. 
Source: Author’s own elaboration based on data from Global Burden of Disease Study 2015. (GBD 2015) Results. Seattle United 
States: Institute for Health Metrics and Evaluation (IHME); accessed: 08.10.2016 [37].
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As can be seen in Table III, all the top ten causes of 
disability in Poland in 2015 were due to NCDs. Lower back 
and neck pain in the first rank (the same as 25 years ago) 
caused the most disability in Poland (803,456 years lived 
with disability) representing a 17.2% increase compared to 
1990. The second rank was held by sense organ diseases, 
which showed an over 30% increase since 1990 and led to 
513,612 YLD in the Polish population in 2015. Depres-
sive disorders in the third rank caused 330,423 YLDs and 
demonstrated an increase by 15.5% since 1990. The largest 
increase of burden in the last 25 year period has been ob-
served in diabetes (77%) which caused 223,139 YLDs and 
moved from 6th to 4th place. Osteoarthritis showed a 48.5% 
increase, causing 118,030 YLDs. Falls demonstrated an 
over 22% decrease and iron deficiency anaemia from the 
first group (communicable diseases) – almost a 26% de-
cline in the last 25 year period.
Table IV shows the leading causes of years of life 
lost due to deaths in Poland in 2015. Seven of the ten 
causes were non-communicable diseases with ischemic 
Chart 1. Global and national in Poland burden of non-communicable diseases expressed in YLLs, YLDs and DALYs, years 
1990–2015
(a) World – both sex groups (b) World – males and females
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heart disease in the top position. Even with five of these 
seven NCD causes having shown a decline in YLL num-
bers, these are still the leading causes of premature death 
in Poland. Three of the causes showed a substantial in-
crease in time lost during the last 25 years: lung cancer 
(by 19.2%), self-harm (by almost 29%), colorectal cancer 
(by 26.4%) and the highest, almost a 50% increase dem-
onstrated by Alzheimer’s disease.
Applying the DALY measure, the main diseases caus-
ing the most death and disability combined in Poland are 
presented in Chart 3.
Eight out of the ten leading causes of death and dis-
ability combined in Poland 2015 were NCDs (Chart 3). 
The top cause of disability adjusted life years in Poland 
in 2015 was ischemic heart disease, which showed a 38% 
decrease compared to 1990. However, it still remains 
the number one cause of years of life lost due to death 
and disability in Poland (accounting for over 1.45 mln 
DALYs in 2015). The second leading cause of burden 
to the Polish population was lower back and neck pain, 
accounting for 803,456 DALYs and presenting a 17% 
increase in the 25 year period. The biggest improve-
Chart 2. Burden of NCDs globally and in Poland, by sex and age groups in 2015
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ment Poland achieved was in preventing consequences 
of road injuries (–46% compared to1990). Unfortunately, 
road injuries still remain among the ten leading causes 
of death and disability (ranking 9th). The DALYs due to 
colorectal cancer in Poland in 2015 were 252,875 and 
presented an almost 30% increase in the last 25 years. 
2.4. Burden of diseases on the working age population 
In 2015 45.7% of all disability adjusted life years 
globally were from the working-age (in 15–59 years of 
life) population (an aggregate distribution of working-age 
DALYs can be seen at Chart 4(a)). In Poland – almost 
47% of DALYs due to all causes were in the working age 
population. Over 66.7% of global DALYs in the working 
age population were due to NCDs, 18.2% due to commu-
nicable diseases and 15.1% due to injuries (Chart 4(a)).
Although the share of non-communicable diseases 
in the overall burden of disease varied in countries with 
different income levels, it was prevailing everywhere. 
In High-Income Countries as in Poland about 82% of 
DALYs in the working age population are due to chronic 
non-communicable diseases.
Chart 4(b) presents the share of working age DALYs 
attributable to the three main groups of diseases in Po-
land. To assure the comparability of results, the identical 
age group of 15–59 years was considered as the working 
age group for analyses performed for both Poland and 
the world. This is the age interval most commonly used 
in publications.
Table III. Leading causes of disability (YLDs) in Poland in 2015 and percent change, 1990–2015
1990 rank 2015 rank % change 1990–2015
Lower back & neck pain 1 1  Lower back & neck pain(803,456) 17.15%
Sense organ diseases 2 2 Sense organ diseases(513,612) 30.03%
Depressive disorders 3 3 Depressive disorders (330,423) 15.49%
Skin diseases 4 4 Diabetes(223,139) 77.02%
Migraine 5 5 Skin diseases (217,884) –0.2%
Diabetes 6 6 Migraine (199,437) 7.71%
Anxiety disorders 7 7 Oral disorders(153,478) 28.95%
Oral disorders 8 8 Anxiety disorders(132,083) 7.76%
Falls 9 9 Osteoarthritis(118,030) 48.53%
Iron deficiency anaemia 10 10 Ischemic heart disease(106,033) 33.12%
11 Falls(86,178) –24.22%
Ischemic heart disease 12 12 Iron deficiency anaemia(83,084) –25.78%
Osteoarthritis 14
  I. Communicable, maternal, neonatal, and nutritional diseases
 II. Non-communicable diseases
III. Injuries
The number of YLDs by cause in 2015 is provided in parentheses. 
Source: Author’s own elaboration based on data from Global Burden of Disease Study 2015. (GBD 2015) Results. Seattle United 
States: Institute for Health Metrics and Evaluation (IHME); accessed: 22.10.2016 [37]. 
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Chart 5 presents the distribution of working-age 
DALYs results for Poland for men and women adopting 
the working age range for women of 18–59 and for men of 
18–64. In the group of women 26.4% of all cause DALYs 
were in the working age (18–59) group, in males it was 
64.6% (in the 18–64 age group), which leads to substantial 
productivity losses for the economy. In women the share of 
working-age DALYs due to NCDs is much higher than in 
men. This is mainly due to the larger share of injuries for 
men (specifically road traffic accidents), which in males 
was 17.37% compared to 6.5% in the female group. 
The impact of NCDs on the working age popula-
tion in Poland in 2015 is substantial. 89.6% of working 
age DALYs in females were due to NCDs, in males – 
80.33%. Females had a higher number of working age 
DALYs due to communicable, maternal, neonatal and 
nutritional disceases than males (3.9% vs. 2.3%).
3. Income lost due to ill health in Poland
The income lost due to diseases is calculated based on 
number of DALYs presented earlier.
3.1. Income lost due to all causes deaths in Poland
The results of applying the WHO Commission on 
Macroeconomics and Health (CMH1 and CMH3) ap-
proach in measuring the income lost due to diseases are 
presented in Chart 6. 
Table IV. Leading causes of premature deaths (YLL) in Poland, 2015 and percent change, 1990–2015
1990 rank 2015 rank % change 1990–2015
Ischemic heart disease 1 1 Ischemic heart disease(1,350,354) –40.7%
Cerebrovascular disease 2 2 Cerebrovascular disease(582,170) –24.2%
Lung cancer 3 3 Lung cancer(518,461) 19.2%
Road injuries 4 4 Self-harm(320,340) 28.7%
Neonatal preterm birth complications 5 5 Colon and rectal cancer(244,347) 26.4%
Congenital anomalies 6 6 Road injuries(188,118) –53.8%
Self-harm 7 7 LRI(175,247) –18.6%
LRI 8 8 Cardiomyopathy(168,506) 7.4%
Colon and rectal cancer 9 9 COPD(158,160) –17.5%
COPD 10 10 Alzheimer’s disease(150,159) 49.5%
Cardiomyopathy 12
Alzheimer’s disease 18
19 Congenital anomalies(75,222) –73.2%
37 Neonatal preterm birth complications (39,470) –86.3%
  I. Communicable, maternal, neonatal, and nutritional diseases
 II. Non-communicable diseases
III. Injuries
LRI = lower respiratory infections; COPD = Chronic Obstructive Respiratory Disease; The number of YLLs by cause in 2015 is presented in 
parentheses. 
Source: Author’s own elaboration based on data from Global Burden of Disease Study 2015. (GBD 2015) Results. Seattle United 
States: Institute for Health Metrics and Evaluation (IHME); accessed: 22.10.2016 [37].
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The total income lost due to all causes in Poland in 
2015 was I$176 bln according to CMH1 and I$527 es-
timated with the CMH3 approach (Chart 6). After dis-
counting with a 3% discount rate the income lost due to 
all causes YLL in Poland 2015 accounted for I$108 bln 
when CMH1 was used and I$324 bln estimated with the 
CMH3 method. Almost 69% of lost income occurred due 
to deaths below the age of 70 and is assumed to have 
been avoidable. 
3.2. Income lost due to NCDs in Poland 2015
Estimated income lost due to non-communicable dis-
eases in Poland 2015 due to NCDs is presented in Table V.
The total economic burden of NCDs in Poland 2015 
estimated with the CMH1 and CMH3 approaches ac-
counted for between I$259 bln and over I$776.7 bln 
(Table V). 57% of the lost income was due to deaths. 
Among them, 61% were below the age of 70, which are 
considered avoidable and the economic loss could have 
been avoided. 
Conclusion
The disease burden globally and in Poland was as-
sessed here with non-monetary units: the death rate and 
a synthetic indicator considering both duration of time 
lost due to deaths and reduced quality of life during dis-
ease – the DALY measure with YLLs and YLDs in its 
construct. The DALY also formed the basis for estimating 
the income lost due to disease in Poland. 
Below are the key findings in the study.
Main causes of deaths both globally and in Poland 
In 2015 the leading causes of deaths globally were 
non-communicable diseases: cardiovascular diseases, 
neoplasms, chronic respiratory disorders, diabetes and 
neurological disorders. Most of them increased or held 
the same high rank during the last 25 years. 
In Poland eight out of the ten top causes were also from 
the NCD group. Most of them moved upward in the rank-
ing during the last 25 years like: diabetes, Alzheimer’s dis-
ease and other dementias, cardiomyopathy and colorectal 
cancer. Others have held their position in the first three 
ranks: ischemic heart disease, cerebrovascular disease 
and lung cancer. Even having achieved a decrease in the 
mortality rate of almost 25% compared to 1990, ischemic 
heart disease is still at the top of the list. Some of substan-
tial changes in disease burden due to deaths elicited in the 
study (the percent increase of death rates in diseases like 
Alzheimer’s disease and other dementia, or diabetes mel-
litus) may be due to an improved diagnosis of the cases or 
as a result of improved recognition by researchers8. 
In 2015, 54% of all deaths globally and about 43% of 
deaths due to NCDs were premature and avoidable (oc-
Chart 3. Leading causes of DALYs in Poland, 2015 and percent change, 1990–2015 
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Source: Author’s own elaboration based on data from Global Burden of Disease Study 2015. (GBD 2015) Results. Seattle United 
States: Institute for Health Metrics and Evaluation (IHME); accessed: 22.10.2016 [37]. 
Zeszyty Naukowe Ochrony Zdrowia188
years of life lost and disability
curring before the age of 70). Compared to the previous 
analyses done by the author [2] there has been a clear 
shift in the age of death in the direction of the older ages. 
The world has achieved an improvement in combat-
ing deaths in the last 25 years. The all cause death rate in 
2015 was 756.92 deaths per 100,000 which, compared to 
1990, has decreased by 16.24%. In Poland the all cause 
death rate in 2015 was 994.13 deaths per 100,000 which, 
compared to 1990, has decreased by 3.02%. 
The burden of non-communicable diseases is growing 
due to the aging population and unhealthy life styles. Due 
to its mass character, this has become a huge burden to 
societies. At present, over 71% of all deaths (accounting 
for over 39.8 mln) globally are due to NCDs [37]. In Po-
land 90% of all deaths in 2015 (accounting for over 348.7 
thousands) are due to NCDs. 32% of these deaths occur 
below the age of 70 and are considered to be avoidable.
The burden of communicable diseases, maternal, 
neonatal and nutritional diseases declined from 1990 to 
2015 – both globally and in Poland, with the bulk of that 
achievement being driven by reductions in the burden of 
child and maternal mortality. In Poland the community 
Chart 4. Distribution of working age DALYs due to three main groups of diseases globally and in Poland, 2015 
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Chart 5. Distribution of working age* DALYs among the main groups of diseases in Poland in 2015, by sex
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Source: Author’s own elaboration based on data from Global Burden of Disease Study 2015. (GBD 2015) Results. Seattle United 
States: Institute for Health Metrics and Evaluation (IHME); accessed: 08.10.2016 [37].
Chart 6. Income lost due to years of life lost caused by deaths in Poland, all causes, both sex groups (in bln I$, 2015 prices) – 
CMH1 and CMH3 methods 
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focus on child survival appears to be reaping rewards as 
the neonatal preterm birth complications cause in 2015 
dropped to the 37th from the 5th rank in 1990 in the top 
leading causes of premature deaths (accounting for an 
over 86% decline in YLLs). 
Main causes of premature deaths – years of life lost in Poland
Over 6.7 mln years of life were lost in Poland in 2015 
due to all causes. 57.4% of these were due to the top ten 
causes (seven of which were NCDs). Compared to 1990, 
Poland has achieved a decrease in the number of YLL by 
24%. Ischemic heart disease caused 1.35 mln YLLs and 
held, as in 1990, the first rank of the diseases causing the 
most premature deaths. 
Main causes of disability and combined death and disability  
in Poland 
All of the top ten causes of disability in Poland 2015 
were non-communicable diseases. These are: lower back 
and neck pain, sense organ diseases, depressive disorders, 
diabetes, skin diseases, migraines, oral disorders, anxiety 
disorders, osteoarthritis and ischemic heart disease. All 
above listed causes, except skin diseases, demonstrated 
a substantial increase of YLDs compared to 1990. The 
highest increase was observed in diabetes mellitus (over 
77%), followed by osteoarthritis (almost 49%), ischemic 
heart disease (over 33%), sense organ disorders (30%) 
and oral disorders (29%). 
The leading causes of DALYs in Poland in 2015 
were ischemic heart disease, lower back and neck pain, 
cerebrovascular disease, lung cancer, sense organ dis-
ease, diabetes, depressive disorders, self-harm, road 
injuries and colorectal cancer. Eight of these are from 
the NCD group. Seven of these causes showed an in-
crease in the last 25 years. In three of them a decrease 
of DALYs was observed: in ischemic heart disease 
(–38%), in cerebrovascular disease (–22%) and in road 
injuries (–46%). 
National income lost due to disease in Poland
The total income lost in Poland in 2015 due to years 
of life lost as a consequence of all cause deaths was be-
tween I$176 bln, estimated with the VSL-CMH1 method, 
and I$527 bln, estimated with VSL-CMH3 method. 69% 
of this dramatic effect could have been saved.
Chronic non-communicable diseases have been es-
tablished as a clear threat not only to human health but 
also to global development. NCDs reduce the national 
income, the supply of labour and productivity, cause ear-
ly retirement, high turnover in the work place and large 
production losses due to a reduction in productivity9. 
Chronic non-communicable diseases affect the economy 
by virtue of the fact that a significant portion of the lost 
life years fall on the working-age.
National income lost due to NCDs in Poland
The distribution of working age DALYs establishes 
the prevailing burden of NCDs in Poland as well as in the 
world. 82% of working age (15–59 years of life) DALYs 
in Poland in 2015, and 67% globally, were due to NCDs. 
NCDs in Polish women cause a larger share of working 
age (18–59 years) DALYs than in men (aged 18–64): al-
most 90% vs. 80%.
The total income lost due to NCDs in Poland (due to 
death and disability, both sex groups) was between I$259 
bln and I$777 bln. The national income that could have 
been saved if the premature deaths had been avoided ac-
counts for between I$91 bln to I$273bln. 
The approximations of income lost in Poland pre-
sented here are probably underestimations because GDP 
growth has not been considered.
A course of action
The world is in the middle of an epidemiological tran-
sition [38]. As countries increase their levels of devel-
opment, their communicable disease burden is declining 
Table V. Income lost due to NCDs in Poland in 2015 estimated with the CMH1 and CMH3 (bln current I$)
Measure
Income lost 
due to NCDs
Males
2015
(CMH1)1
Income lost 
due to NCDs
Females
2015
(CMH1)
Income lost due 
to NCDs
Both sex groups
2015
(CMH1)
(%)
Income lost due to 
NCDs
Males
2015
CMH32 
Income lost due 
to NCDs
Females
2015
CMH3
Income lost due 
to NCDs
Both sex groups
2015
CMH3
YLD 50.2 59.9 110.1 43% 150.6 179.7 330.3
YLL 89.5 59.3 148.8 57% 268.5 177.9 446.4
DALY 139.7 119.2 258.9 100% 419.1 357.6 776.7
1 CMH1 when 1 × GDP per capita is applied.
2 CMH3 when 3 × GDP per capita is used.
Source: Author’s own elaboration based on data from Global Burden of Disease Study 2015. (GBD 2015) Results. Seattle United 
States: Institute for Health Metrics and Evaluation (IHME); accessed: 08.10.2016 [37], World Bank, World Development Indi-
cators, GDP per capita PPP (current international $) [43], World Bank, World Development Indicators, GDP deflators [40] and 
World Bank, World Development Indicators, PPP conversion factor, GDP (Local Currency Unit per international $), International 
Comparison Program database [41]. 
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and non-communicable disease burden is raising. The 
disease burden change is mainly through an increase in 
burden due to disability. 
Poland has achieved an impressive decline in the 
number of DALYs due to causes like ischemic heart dis-
ease, cerebrovascular diseases, road injuries and neonatal 
preterm birth complications. However there is still a lot 
of work to do in combating NCDs. 
Overall, the extent of the burden of non-communicable 
diseases is rising. The burden of some non-communicable 
diseases has declined, but generally not quickly enough 
to overtake the rate of population growth. As populations 
grow and increase in average age, however, the total bur-
den of disability is rising quickly [38]. While development 
drives many positive changes in health outcomes, certain 
diseases (such as ischemic heart disease and diabetes) tend 
to worsen with development and need preventive actions. 
The DALY measure, the principal metric of the GBD 
study, helps decision-makers compare the impact of dif-
ferent diseases and injuries not just in terms of early death 
but also in terms of disability and suffering. Now re-
searchers are focusing on transferring the analyses of bur-
den of diseases to local, regional and county levels. The 
aim is to increase the impact of burden of disease analyses 
on improving decentralized health policy making. 
Notes
1 1) GDB results released in 1993–1995: six classes of dis-
ability were used to estimate the average disability weights for 
both treated and un-treated forms of a disease [3, 10]; 2) results 
published in 1996–2009, in which disability weights based on 
7 classes of disability were used. Both of the stages described 
above took into consideration social preferences – age weight-
ing (differentiated values depending on the age of a person – 
reflecting changes in the way the value of an individual’s life 
during the life cycle is assessed); 3) Work in years 2010–2013, 
during which the new GBD-2010 methodology was introduced 
and results released in 2012 [11]. This was the first significant 
revision in the approach to calculating DALY in that it: (i) 
eliminates age weights in the YLD and YLL calculation mod-
els; (ii) uses a morbidity approach to calculate YLD; (iii) intro-
duces a new standard life expectancy at each age that is equal 
for women and men in order to avoid gender inequalities when 
assessing disease burden and health programmes (in previous 
studies males had a lower life expectancy at birth than females); 
4) The recently published GBD-2015 assessment of disease 
burden [12, 13], as the authors have declared, provides new and 
more robust evidence on the health of populations worldwide 
through the inclusion of an expanded group of countries and 
data sources. The new data set – the entire time series from 
1990 to 2015 – has been updated on the basis of newly identi-
fied data sources released or collected since GBD 2013 [12, 
13]. As a consequence, the 2015 results may differ from the 
previous findings for particular years.
2 Examples of assessing the disease burden in Poland (using 
the old methodology – the first three stages of the GBD study 
described above) have been given elsewhere [2, 14, 15].
3 The results were presented in September 2011 at a United 
Nations High Level Summit devoted to problems associated 
with chronic non-communicable diseases.
4 The EPIC model is the standard model of economic 
growth. It reflects gross domestic product depending on capi-
tal and labour inputs, a relationship that is also mediated by 
technology and productivity. The basic assumption is that if it 
were not for chronic non-communicable diseases there would 
be more resources of labour and physical capital available, and 
thus GDP would be higher. Chronic non-communicable diseas-
es are introduced into the model with the assumption that they 
have a destructive impact on both physical capital and labour 
capital. Physical capital is reduced as a result of diminished 
savings (and, in turn, lower investment) due to the increased 
consumption of medical services for individuals with chronic 
diseases.  Labour resources are depleted as a result of mortal-
ity caused by chronic diseases. This model does not take into 
account domestic growth in human capital or technological 
progress due to expenditure on research and development. It 
likewise does not reflect any changes in the savings rate in so-
ciety as a result of mortality caused by chronic diseases (a fixed 
savings rate is assumed). The model only considers mortality 
caused by chronic diseases, while overlooking any losses in 
capital and labour caused by morbidity [16].
5 Non-communicable diseases are identified by WHO 
as “Group II Diseases”, a category that aggregates (based on 
ICD-10 code) the following of conditions/causes of death and 
disability: malignant neoplasms, other neoplasms, diabetes mel-
litus, endocrine disorders, neuropsychiatric conditions, sense 
organ diseases, cardiovascular diseases, respiratory diseases 
(e.g. chronic obstructive pulmonary disease – COPD, asthma, 
other), digestive diseases, genitourinary diseases, skin diseases, 
musculoskeletal diseases (e.g., rheumatoid arthritis), congenital 
anomalies (e.g., cleft palate, down syndrome), and oral con-
ditions (e.g., dental caries). These are separate from “Group 
I Diseases” (communicable, maternal, perinatal and nutritional 
conditions) and “Group III Diseases” (unintentional and inten-
tional injuries).
6 With a tool called DisMod-MR 2.1 (Disease Modeling- 
-Metaregression).
7 Working age refers to that age range within which people 
are usually employed in some form of work. Depending on the 
classification used, working age covers the following groups: 
women aged between 15 or 18 and 59 and men aged between 
15 or 18 and 59 or 64. According to the methodology employed 
by the Central Statistical Office of Poland, the following groups 
are of working age: men between 18 and 64 and women be-
tween 18 and 59.
8 This issue was raised during the Meeting: “Development 
is Not Destiny”, the launch of the annual Global Burden of 
Diseases, Injuries, and Risk Factors Study on Friday, Oct. 7 
in Washington D.C; the event was co-sponsored by the World 
Bank Group, The Lancet, and the Institute for Health Metrics 
and Evaluation (IHME) at the University of Washington.
9 Considering these facts, the UN held on 19–20 September 
2011 in New York City the First High Level UN Summit on 
chronic NCDs. World leaders have agreed to meet to focus on 
global action that will reverse the NCD epidemic.
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